This month, researchers from Georgetown University stumbled across unexpected cognitive benefits while testing a drug meant to aid the fight against leukemia. The medication is already FDA approved for patients with leukemia, but tests for those with Parkinson’s are still ongoing. However, the researchers are hopeful that further experiments will prove the drug safe for use in treating conditions of the brain and nervous system.
According to the university, people with Parkinson’s disease who took the drug, which is known as nilotinib, saw improved motor function, non-motor function and cognition.
What is Parkinson’s disease?
According to the Mayo Clinic, Parkinson’s disease …read more